GlobalData on MSN18d
GT Medical secures $37m in Series D funding to advance trials of GammaTileGT Medical Technologies has secured a $37m first close of a Series D funding round to expedite the completion of pivotal clinical studies for its bioresorbable radiotherapy implant, GammaTile Therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback